Portside Wealth Group’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$821K Buy
1,315
+40
+3% +$23.4K 0.09% 218
2026
Q2
$675K Buy
1,275
+133
+12% +$61.4K 0.08% 248
2026
Q1
$548K Buy
1,142
+36
+3% +$18.4K 0.07% 240
2025
Q4
$621K Buy
1,106
+31
+3% +$17.6K 0.08% 216
2025
Q3
$553K Sell
1,075
-15
-1% -$6.55K 0.08% 238
2025
Q2
$342K Buy
1,090
+27
+3% +$8.11K 0.05% 321
2025
Q1
$324K Buy
1,063
+160
+18% +$53.8K 0.05% 314
2024
Q4
$300K Buy
903
+115
+15% +$39K 0.05% 328
2024
Q3
$263K Buy
788
+9
+1% +$3.42K 0.04% 330
2024
Q2
$321K Sell
779
-492
-39% -$195K 0.06% 263
2024
Q1
$514K Sell
1,271
-148
-10% -$52K 0.1% 216
2023
Q4
$435K Buy
1,419
+183
+15% +$49.4K 0.08% 223
2023
Q3
$298K Buy
1,236
+99
+9% +$25.3K 0.06% 250
2023
Q2
$273K Buy
+1,137
New +$236K 0.05% 273

Other funds holding MEDP

Portside Wealth Group's MEDP Position: Q3 2026 in Review

Portside Wealth Group increased its Medpace (MEDP) stake by 3.1% in Q3 2026, buying an estimated $23.4K and bringing the position to 1,315 shares worth $821K. The position accounts for 0.09% of the portfolio, ranked #218.

Portside Wealth Group first reported a position in MEDP in Q2 2023 and has held it in 14 quarters since. 183 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Portside Wealth Group held 1,315 shares of Medpace worth $821K as of Q3 2026.
  • Portside Wealth Group bought 40 Medpace shares in Q3 2026, an estimated $23.4K.
  • Medpace made up 0.09% of Portside Wealth Group's portfolio in Q3 2026, its #218 holding.
  • Portside Wealth Group first reported a position in Medpace in Q2 2023 and has held it in 14 quarters since.
  • 183 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Portside Wealth Group's 13F filing for Q3 2026, filed 20 Oct 2026.